APA (7th ed.) Citation

Singer, J., Weichselbaumer, M., Stockner, T., Mechtcheriakova, D., Sobanov, Y., Bajna, E., . . . Jensen-Jarolim, E. (2012). Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting. Molecular Immunology, 50(4), 200. https://doi.org/10.1016/j.molimm.2012.01.002

Chicago Style (17th ed.) Citation

Singer, Josef, et al. "Comparative Oncology: ErbB-1 and ErbB-2 Homologues in Canine Cancer Are Susceptible to Cetuximab and Trastuzumab Targeting." Molecular Immunology 50, no. 4 (2012): 200. https://doi.org/10.1016/j.molimm.2012.01.002.

MLA (9th ed.) Citation

Singer, Josef, et al. "Comparative Oncology: ErbB-1 and ErbB-2 Homologues in Canine Cancer Are Susceptible to Cetuximab and Trastuzumab Targeting." Molecular Immunology, vol. 50, no. 4, 2012, p. 200, https://doi.org/10.1016/j.molimm.2012.01.002.